Article
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis.
American journal of hematology - 1 Jul 2016
Rosti Vittorio, Campanelli Rita, Massa Margherita, Viarengo Gianluca, Villani Laura, Poletto Valentina, Bonetti Elisa, Catarsi Paolo, Magrini Umberto, Grolla Ambra A, Travelli Cristina, Genazzani Armando A, Barosi Giovanni
Abstract excerpt
Myeloproliferative neoplasm (MPN)-associated myelofibrosis is a clonal, neoplastic disorder of the hematopoietic stem cells, in which inflammation and immune dysregulation play an important role. Extracellular nicotinamide phosphoribosyltransferase (eNAMPT), also known as visfatin, is a cytokine implicated in a number of inflammatory and neoplastic diseases. Here plasma levels of eNAMPT in patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
